Background: Mutations in the NPHS2 gene, encoding podocin, and in the ACTN4 gene, encoding α-actinin-4, have been identified in familial childhood-onset forms of focal and segmental glomerulosclerosis (FSGS). NPHS2 may be also responsible for some sporadic cases. The role of NPHS2 and ACTN4 in the adult sporadic form of the disease is being clarifying. Methods: Thirty-three adult subjects affected by sporadic FSGS were studied at molecular level. At biopsy, 12 patients had nephrotic syndrome, 5 patients had isolated proteinuria and 16 patients showed proteinuria and hematuria. Glomerular filtration rate (GFR) was in the normal range in 19 subjects and 14 patients had a variable degree of renal failure. Multiplex families presenting with a clear familial inheritance for proteinuria or other congenital nephrotic syndrome were excluded. The whole coding region, all intron/exon boundaries and flanking intronic regions of NPHS2 gene and the exon 8, i.e. hot-spot mutations of the ACTN4 gene, were analyzed in all patients by denaturing high-performance liquid chromatography (DHPLC) to search disease-causing defects. Results: The analysis identified four already described and two new polymorphisms, IVS3–21C>T and IVS3–46C>T, on the NPHS2 gene. Moreover, the R229Q allele was identified in 3/33 patients and in 7/124 controls, accounting for an allelic frequency of 0.045 and 0.028, respectively. The new intronic polymorphism IVS7–54C>T was also found in the exon 8 of the ACTN4 gene. Conclusions: In this study, we exhaustively analyzed the NPHS2 and the exon 8 of the ACTN4 genes in a series of sporadic ‘adult-onset’ FSGS patients. No causative mutations were found while the R229Q allele was identified in 3 patients confirming its possible role as a ‘disease-associated NPHS2 allele’ although its pathogenetic involvement needs to be further clarified. Moreover, the description of new intronic polymorphisms in both genes is reported.

Keywords:
Actinin-4, Denaturing high-performance liquid chromatography, Focal segmental glomerulosclerosis, Podocin
1.
Braden GL, Mulhern JG, O’Shea MH, et al: Changing incidence of glomerular diseases in adults. Am J Kid Dis 2000;35:878.
2.
D’Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 1994;46:1223.
3.
Pollak MR: Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 2002;13:3016–3023.
4.
Antignac C: Genetic models: Clues for understanding the pathogenesis of idiopathic nephrotic syndrome. J Clin Invest 2002;109:447–449.
5.
Kaplan J, Pollak MR: Familial focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens 2001;10:183–187.
6.
Kestila M, Lenkerri U, Mannikko M, et al: Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1988;1:575–582.
7.
Boute N, Gribouval O, Roselli S, et al: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24:349.
8.
Kaplan JM, H Kim S, North KN, et al: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251.
9.
Winn MP, Conlon PJ, Lynn KL et al: Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999;58:113.
10.
Caridi G, Berdeli A, Dagnino M, Di Duca M, Mir S, Cura A, Ravazzolo R, Ghiggeri GM: Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin. Am J Kidney Dis 2004;43:727–732.
11.
Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, et al: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:2742–2746.
12.
Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A, and the Arbeitsgemeinschaft für pädiatrische Nephrologie: Novel mutations in NPHS2 detected in both familial and sporadic steroid resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:388–393.
13.
Caridi G, Bertelli R, Di Luca M, et al: Broadening the spectrum of disease related to podocin mutations. J Am Soc Nephrol 2003;14:1278–1286.
14.
Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Members of the APN Study Group, Hildebrandt F: Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004;15:722–732.
15.
Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, et al: NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002;110:1659–1666.
16.
Caridi G, Bertelli R, Scolari F, Sanna-Cherchi S, Di Duca M, Ghiggeri GM: Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 2003;64:365.
17.
Rozen S, Skaletsky HJ: Primer 3 on the www for general users and for biologist programmers; in Krawetz S, Misener S (eds): Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, Humana Press, 2000, pp 365–386. (Code available at http://www.genome.wi.mit.edu/genome_software/other/primer3.html.)
18.
Winn MP: Not all in the family: Mutations of podocin in sporadic steroid resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:577–579.
19.
Niaudet P: Podocin and nephrotic syndrome: Implications for the clinician. J Am Soc Nephrol 2004;15:832–834.
20.
Koziell A, Grech V, Hussain S, et al: Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 2002;11:379–388.
21.
Pereira AC, Pereira AB, Mota GF, et al: NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004;65:1026–1030.
22.
Xiao W, Oefner PJ: Denaturing high-performance liquid chromatography: A review. Hum Mut 2001;17:439–474.
23.
Bertelli R, Ginevri F, Caridi G, et al: Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am Kidney Did 2003;41:1314–1321.
24.
Le Berre L, Godfrin Y, Gunther E, et al: Extrarenal effects on the pathogenesis and relapse of idiopathic nephritic syndrome in Buffalo/Mna rats. J Clin Invest 2002;109:491–498.
© 2005 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.